Current Vascular Pharmacology


Dimitri P. Mikhailidis
(33295 citations)
Academic Head, Department of Clinical Biochemistry
Royal Free Hospital Campus
University College London Medical School
University College London (UCL)
Pond Street
London, NW3 2QG

Personal Subscription
Become EABM
Become Reviewer

Editorial [Hot Topic: HDL Proteome: New Possibilities in the Treatment of Cardiovascular Disease (Guest Editors: Elena Burillo and Fernando Civeira)] promotion: free to download

Volume:10   Issue: 4
Pp: 391-391
Elena Burillo and Fernando Civeira
DOI: 10.2174/157016112800812773

HDL-Related Mechanisms of Olive Oil Protection in Cardiovascular Disease

Volume:10   Issue: 4
Pp: 392-409
Jose M. Lou-Bonafonte, Montse Fito, Maria-Isabel Covas, Marta Farras and Jesus Osada
DOI: 10.2174/157016112800812827

Lipid and Apoprotein Composition of HDL in Partial or Complete CETP Deficiency

Volume:10   Issue: 4
Pp: 422-431
Eric J. Niesor, Elisabeth von der Mark, Laura Calabresi, Maurizio Averna, Angelo B. Cefalu, Patrizia Tarugi, Peter Nilsson and Gregor Dernick
DOI: 10.2174/157016112800812683

Omega-3 Fatty Acids and HDL. How Do They Work in the Prevention of Cardiovascular Disease?

Volume:10   Issue: 4
Pp: 432-441
Elena Burillo, Paula Martin-Fuentes, Rocio Mateo-Gallego, Lucia Baila-Rueda, Ana Cenarro, Emilio Ros and Fernando Civeira
DOI: 10.2174/157016112800812845

Editorial [Hot Topic: Current Antithrombotic Management of ST Elevation Acute Coronary Syndromes in the Cath Lab – A Paradigm Shift (Guest Editor: Bernardo Cortese)] promotion: free to download

Volume:10   Issue: 4
Pp: 442-442
Bernardo Cortese
DOI: 10.2174/157016112800812791

GP IIb/IIIa Inhibitors for STEMI: Still the Gold Standard or an Old Survivor?

Volume:10   Issue: 4
Pp: 443-447
Giuseppe Musumeci, Matteo Baroni and Roberta Rossini
DOI: 10.2174/157016112800812737

Intracoronary Use of GP IIb/IIIa Inhibitors in Percutaneous Coronary Interventions

Volume:10   Issue: 4
Pp: 448-453
Maria De Vita, Valentina Coluccia, Francesco Burzotta, Enrico Romagnoli and Carlo Trani
DOI: 10.2174/157016112800812764

Prasugrel During Primary Percutaneous Coronary Intervention: Evidence from Clinical Data

Volume:10   Issue: 4
Pp: 454-457
Giuseppe Biondi-Zoccai, Antonio Abbate, Fabrizio D’Ascenzo, Marzia Lotrionte and Maria G. Modena
DOI: 10.2174/157016112800812782

Ticagrelor in ST-Elevation Myocardial Infarction

Volume:10   Issue: 4
Pp: 458-462
Gregory A. Sgueglia, Giuseppe Tarantini and Giampaolo Niccoli
DOI: 10.2174/157016112800812728

Prevention and Treatment of Coronary Distal Embolization in the Setting of Acute Myocardial Infarction: Pharmacologic Approach

Volume:10   Issue: 4
Pp: 463-467
Alberto R. De Caterina, Italo Porto, Giovanni Luigi De Maria and Adrian P. Banning
DOI: 10.2174/157016112800812809

Cilostazol and Primary-PCI: Mirage or Good Alternative?

Volume:10   Issue: 4
Pp: 468-471
Italo Porto, Domenico D’Amario and Filippo Crea
DOI: 10.2174/157016112800812854

Drug Coated Balloons in Acute Coronary Syndromes - Opportunities and Limitations

Volume:10   Issue: 4
Pp: 472-475
Bruno Scheller, Yvonne Clever, Michael Bohm and Bodo Cremers
DOI: 10.2174/157016112800812692

In the Bivalirudin Era, Are We Still Looking for a Potent Antiplatelet Agent?

Volume:10   Issue: 4
Pp: 476-478
Bernardo Cortese, Antonino Pitì, Adnan Kastrati and Dirk Sibbing
DOI: 10.2174/157016112800812700

Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies

Volume:10   Issue: 4
Pp: 479-493
Patrizia Ferroni, David Della-Morte, Raffaele Palmirotta, Tatjana Rundek, Fiorella Guadagni and Mario Roselli
DOI: 10.2174/157016112800812836

Antiplatelet Therapy in Patients with Diabetes Mellitus

Volume:10   Issue: 4
Pp: 494-505
Erik L. Grove and Soren Gregersen
DOI: 10.2174/157016112800812818

Blood Pressure Control and Antihypertensive Treatment

Volume:10   Issue: 4
Pp: 506-511
Guido Grassi, Gino Seravalle, Fosca Quarti Trevano, Raffaella Dell’Oro and Giuseppe Mancia
DOI: 10.2174/157016112800812719

Cytochrome P450 1B1 and 2C9 Genotypes and Risk of Ischemic Vascular Disease, Cancer, and Chronic Obstructive Pulmonary Disease

Volume:10   Issue: 4
Pp: 512-520
Diljit Kaur-Knudsen, Stig E. Bojesen and Borge G. Nordestgaard
DOI: 10.2174/157016112800812746